Catalio Capital Management, Lp Portfolio Stock Holdings
Catalio Capital Management, Lp disclosed 41 stock positions valued at approximately $478.7 million in its latest SEC 13F filing. The largest holdings include DIANTHUS THERAPEUTICS INC, BRIDGEBIO PHARMA INC, and ASCENDIS PHARMA A/S. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 41
- Portfolio Value
- $478.7M
Holdings by Sector
Catalio Capital Management, Lp Portfolio Holdings in Q1 2026
33 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| DIANTHUS THERAPEUTICS INC | DNTH | Healthcare | 9.82% | 560,308 | -93,264 | -14.27% | $47,021,047 |
| BRIDGEBIO PHARMA INC | BBIO | Healthcare | 6.70% | 432,014 | +432,014 | +100.00% | $32,081,360 |
| ASCENDIS PHARMA A/S | ASND | Healthcare | 6.17% | 129,111 | +9,846 | +8.26% | $29,531,559 |
| BRISTOL-MYERS SQUIBB CO | BMY | Healthcare | 5.33% | 420,727 | -227,172 | -35.06% | $25,517,093 |
| SYNDAX PHARMACEUTICALS INC | SNDX | Healthcare | 5.09% | 1,043,670 | -153,137 | -12.80% | $24,380,131 |
| GILEAD SCIENCES INC | GILD | Healthcare | 4.77% | 163,905 | -125,407 | -43.35% | $22,843,440 |
| TERNS PHARMACEUTICALS INC | TERN | Healthcare | 4.50% | 409,031 | +272,073 | +198.65% | $21,564,114 |
| SOLENO THERAPEUTICS INC | SLNO | Healthcare | 4.04% | 577,808 | +217,468 | +60.35% | $19,345,012 |
| BOSTON SCIENTIFIC CORP | BSX | Healthcare | 3.92% | 299,318 | -61,110 | -16.95% | $18,782,205 |
| ULTRAGENYX PHARMACEUTICAL IN | RARE | Healthcare | 3.72% | 850,797 | +688,247 | +423.41% | $17,824,197 |
| INCYTE CORP | INCY | Healthcare | 3.58% | 182,101 | +182,101 | +100.00% | $17,139,346 |
| CYTOKINETICS INC | CYTK | Healthcare | 2.97% | 215,501 | -42,880 | -16.60% | $14,203,671 |
| NATERA INC | NTRA | Healthcare | 2.96% | 70,907 | +8,634 | +13.86% | $14,180,691 |
| CORVUS PHARMACEUTICALS INC | CRVS | Healthcare | 2.73% | 891,933 | +891,933 | +100.00% | $13,048,980 |
| STRUCTURE THERAPEUTICS INC | GPCR | Healthcare | 2.57% | 255,379 | +2,478 | +0.98% | $12,309,268 |
| MINERALYS THERAPEUTICS INC | MLYS | Healthcare | 2.48% | 439,041 | +107,192 | +32.30% | $11,893,621 |
| EDWARDS LIFESCIENCES CORP | EW | Healthcare | 2.42% | 144,607 | -42,441 | -22.69% | $11,580,129 |
| ADAPTIVE BIOTECHNOLOGIES COR | ADPT | Healthcare | 2.10% | 722,784 | -98,411 | -11.98% | $10,032,242 |
| KALVISTA PHARMACEUTICALS INC | KALV | Healthcare | 1.79% | 426,551 | +426,551 | +100.00% | $8,586,472 |
| DISC MEDICINE INC | IRON | Healthcare | 1.64% | 122,978 | +12,551 | +11.37% | $7,863,213 |
| ABIVAX SA | ABVX | Healthcare | 1.10% | 47,193 | -51,321 | -52.10% | $5,254,941 |
| DYNE THERAPEUTICS INC | DYN | Healthcare | 1.07% | 282,954 | -236,761 | -45.56% | $5,129,956 |
| ELEDON PHARMACEUTICALS INC | ELDN | Healthcare | 1.06% | 1,639,816 | +379,996 | +30.16% | $5,050,633 |
| SUPERNUS PHARMACEUTICALS | SUPN | Healthcare | 0.67% | 62,019 | -195,446 | -75.91% | $3,205,762 |
| PROTARA THERAPEUTICS INC | TARA | Healthcare | 0.63% | 580,024 | -866,230 | -59.89% | $3,021,925 |
| PHATHOM PHARMACEUTICALS INC | PHAT | Healthcare | 0.58% | 247,767 | -451,229 | -64.55% | $2,752,691 |
| NEWAMSTERDAM PHARMA COMPANY | NAMSW | Other | 0.56% | 83,554 | +83,554 | +100.00% | $2,674,564 |
| TYRA BIOSCIENCES INC | TYRA | Healthcare | 0.54% | 67,285 | +67,285 | +100.00% | $2,577,016 |
| IMMUNOCORE HLDGS PLC | IMCR | Healthcare | 0.53% | 84,352 | +84,352 | +100.00% | $2,543,213 |
| FRACTYL HEALTH INC | GUTS | Healthcare | 0.53% | 5,491,866 | - | - | $2,514,176 |
| HYPERFINE INC | HYPR | Healthcare | 0.30% | 1,320,041 | - | - | $1,425,644 |
| METAGENOMI THERAPEUTICS INC | MGX | Healthcare | 0.15% | 528,993 | - | - | $708,851 |
| OUTSET MED INC | 690145206 | Other | 0.09% | 118,279 | - | - | $454,191 |